Overall rank by patents
#8,160
of 50,000 tracked assignees
USPTO PatentsView assignee record - 39 granted patents across 2 technology areas, recorded in grant years 2021–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: F41G (WEAPON SIGHTS; AIMING).
The verdict
According to USPTO PatentsView, Arisaka ranks #8,160 of 50,000 tracked US assignees by granted-patent volume, with 39 patents across 2 technology areas.
Arisaka Llc has been granted 39 US utility patents between 2021 and 2025, placing Arisaka Llc at #8,160 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 2 distinct Cooperative Patent Classification (CPC) subclasses, averaging 1.9 claims per patent with primary concentration in F41G (WEAPON SIGHTS; AIMING). As a US Corporation, Arisaka Llc is one of the more focused assignees in the PatentsView dataset. By volume, Arisaka sits between Aldeyra Therapeutics, Inc. (39 patents, rank #8,160) and Base Brands, Llc (39 patents, rank #8,168) - the closest US assignees by grant volume. The composite Innovation Score of 38.9/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Grant cadence records the difference between two grant-year windows. Historical data spans 2021 through 2025, with 39 total grants over that period. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The US Corporation classification provides context for the assignee record, not a conclusion about its business strategy.
Claim depth and technology breadth describe this aggregate record. Arisaka Llc's 1.9 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 2 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Aldeyra Therapeutics, Inc.
39 patents
American Science and Engineering, Inc.
39 patents
Apeel Technology, Inc.
39 patents
Apollo Tyres Global R&D B.V.
39 patents
AvicenaTech, Corp.
39 patents
Axogen Corporation
39 patents
BackBeat Medical, LLC
39 patents
Base Brands, LLC
39 patents
Arisaka LLC
39 patents
What this shows Arisaka holds 39 patents at rank #8,164, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #8,164 in granted patent volume.
Other assignees with the most granted patents in Arisaka's primary technology class.
Arisaka's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
39 Top 40% higher than 60% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2021 | 1 | 2.6% |
| 2022 | 5 | 12.8% |
| 2023 | 9 | 23.1% |
| 2024 | 14 | 35.9% |
| 2025partial year | 10 | 25.6% |
Top 2 of 2 technology areas
Historical grant data only; it does not rate legal strength or current strategy.
Overall rank by patents
#8,160
of 50,000 tracked assignees
38.9 out of 100
How to use this portfolio
Arisaka's 39 grants land it in the top 40% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.